Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemiaLinde Dekker, Stefan Nierkens, Friso Calkoen et al.|Blood Advances|2022Cited by 89
Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantationRick Admiraal, Caroline A. Lindemans, Stefan Nierkens et al.|Blood Advances|2025Cited by 21
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysisAndrew D.J. Pearson, Gilles Vassal, Claudia Rössig et al.|The Lancet Oncology|2025Cited by 9
Second‐line treatment for acute graft‐versus‐host disease with mesenchymal stromal cells: A decision modelFrederick W. Thielen, Carin A. Uyl‐de Groot, Hedwig M. Blommestein et al.|European Journal Of Haematology|2018Cited by 6
A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System MalignanciesJacob S Rozowsky, Jasper van der Lugt, Joyce I. Meesters-Ensing et al.|Frontiers in Immunology|2022Cited by 4